Patient Capital Management, LLC
BALTIMORE, MD · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.98B2026 Q3+ $167.2M options (notional, not included)
Positions41
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.50.4%
What Changed This Quarter?
Top Holdings
RPRX
Royalty Pharma
6.3%
C
Citigroup
5.7%
GOOGL
Alphabet
5.7%
AMZN
Amazon
5.4%
NVDA
NVIDIA
5.2%
UNH
UnitedHealth
5.0%
PGEN
Precigen
4.9%
META
Meta Platforms
4.2%
New / Increased
4 new · 6 increased
Meta PlatformsCALLNEW
Meta Platforms
4.0%
AVGONEW
Broadcom
2.7%
IDRVNEW
Ishares Tr
0.0%
XHBNEW
SPDR Series
0.0%
QXO
Qxo
4.1%
+53.2%
CHYM
Chime Financial
4.0%
+15.9%
ADBE
Adobe
3.1%
+10.9%
META
Meta Platforms
4.2%
+6.0%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.